Executive Summary
The 15 filings are dominated by routine governance and capital-structure housekeeping rather than operating updates: Apple's $7.5B seven-tranche debt offering is the only material capital-markets event, while 3M and Apple each retired a debt series and several boards refreshed membership.
Insider activity is the most actionable thread: Procter & Gamble's CFO sold $5.18M of stock (exercising at $78.52 and selling at $169.00) and its Grooming CEO sold $908K, while Coca-Cola's EVP sold $1.97M after an option exercise — three senior consumer-staples executives monetizing into strength within one filing window. Microsoft's board will shrink to 11 as director Walmsley withdraws her nomination, and UnitedHealth added a healthcare-operations heavyweight to its board, both governance signals with no financial restatement. Apple's debt raise extends its maturity ladder to 2036 at coupons up to 5.350%, a reminder that even the strongest balance sheets are terming out liabilities at higher rates. Overall sentiment is neutral-to-negative, with no guidance changes, no M&A, and no dividend or buyback actions disclosed; the digest is therefore a positioning and monitoring brief rather than a fundamental re-rating event.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K · Form 4 · DEFA14A
Tracking the trend? Catch up on the prior Dow Jones 30 Stocks SEC Filings digest from November 06, 2026.
Investment Signals (11)
- Procter & Gamble ↓ (BEARISH)▲
CFO Schulten Andre exercised 30,677 options at $78.52 and sold the same 30,677 shares at $169.00 for ~$5.18M, a 115% gain crystallized in one transaction; combined with Grooming CEO Santos de Azevedo's 5,370-share sale at $169.00 (~$908K), two senior insiders sold into the same price level on the same day
- Coca-Cola ↓ (BEARISH)▲
EVP Quan Nancy exercised 20,585 options at $50.44 and sold at $95.62 (~$1.97M), a 90% gain, while retaining 223,330 shares — a partial monetization rather than an exit, but the second consumer-staples insider sale in the window
- ▲
$7.5B debt offering across seven tranches (2028–2036) with the largest single tranche $2.0B of 5.350% notes due 2036; the floating-rate 2028–2029 tranches ($1.25B) suggest a deliberate mix of duration and rate exposure, and the deal was underwritten by Goldman, BofA, Deutsche Bank and J.P. Morgan [NEUTRAL/BULLISH — liquidity strength]
- Apple ↓ (BULLISH)▲
Simultaneous retirement of Senior Notes Due 2026 (Nasdaq Form 25-NSE) alongside the new $7.5B raise indicates active liability management — refinancing maturing debt into a longer ladder rather than net-new leverage
- ▲
Redemption at maturity of its 1.500% Notes due 2026 (NYSE Form 25-NSE, effective November 20, 2026) removes low-coupon legacy debt; routine deleveraging with no distress signal [NEUTRAL/BULLISH]
- Microsoft ↓ (NEUTRAL)▲
Board shrinks to 11 as director Emma Walmsley withdraws her re-election nomination at the December 8, 2026 annual meeting, with no disagreement cited; 10 of 11 remaining nominees independent, average tenure 6.8 years, four women
-
Appointment of Madeline S. Bell, former CEO of Children's Hospital of Philadelphia (four decades at CHOP, CEO 2015–2026), adds deep provider-side operating experience to the board effective November 9, 2026 [BULLISH — governance depth]
- Nike ↓ (NEUTRAL)▲
Dan McKenzie returns as VP, Chief Accounting Officer and principal accounting officer effective November 9, 2026, on a $500K salary, 50% target bonus and $525K LTI target plus a $600K sign-on RSU grant; CFO David Denton sheds the interim controller role, clarifying the finance org
- Amgen ↓ (NEUTRAL)▲
Four independent directors (Ishrak, Gibbs, Drake, Holley) received routine equity awards totaling ~729 shares; no open-market purchases or sales, consistent with standard director compensation
- Travelers ↓ (NEUTRAL)▲
Director Goldwasser Lesley awarded 280 shares at $402.89 (~$113K); routine grant, no signal on the underwriting cycle
- Microsoft ↓ (NEUTRAL)▲
CEO Nadella Satya gifted 4,704 shares and retains 482,058.534 shares — a charitable/estate transfer rather than a sale, so no bearish read-through
Risk Flags (9)
-
CFO sold 30,677 shares (~$5.18M) and Grooming CEO sold 5,370 shares (~$908K) at the identical $169.00 price on the same day — clustered senior selling at a common level is a classic near-term valuation caution flag [HIGH RISK — insider sentiment]
- Coca-Cola↓ [MEDIUM RISK]▼
EVP Quan Nancy's $1.97M sale at $95.62 (vs $50.44 exercise price) is the second consumer-staples executive monetization in the window; watch for follow-on Form 4s from other named officers
- ▼
New 2036 notes carry a 5.350% coupon, locking in a materially higher cost of debt than the 1.500% 3M notes being retired elsewhere in the tape; rising interest expense is a multi-year EPS headwind even for AAA-quality issuers [MEDIUM RISK — cost of capital]
- Apple↓ [MEDIUM RISK]▼
$7.5B raise in a single day, with $1.25B floating-rate exposure, adds rate sensitivity to the 2028–2029 maturities; if the Fed path shifts, floating coupons reprice quarterly beginning February 9, 2027
- Microsoft↓ [LOW-MEDIUM RISK]▼
Board contraction to 11 and the unplanned withdrawal of a director weeks before the December 8 annual meeting creates a governance headline risk, even with no stated disagreement; watch proxy advisor commentary
- ▼
Principal accounting officer transition (McKenzie returning after a July 2026 retirement, Denton stepping back from interim controller) concentrates financial-reporting responsibility in a rehired executive; any restatement or control issue would be magnified [LOW-MEDIUM RISK — controls]
- Nike↓ [LOW RISK]▼
McKenzie's noncompete pays 12 months of base salary if terminated without cause but only one-twenty-fourth per month on voluntary resignation — a retention structure that signals the company views the role as flight-risk-sensitive
- 3M↓ [LOW RISK]▼
While the note redemption is routine, it removes a 1.500% coupon from the stack; in a 5%+ rate environment, refinancing any remaining low-coupon debt raises future interest costs
- Dow 30 tape▼
Across 15 filings there were zero guidance raises, zero dividend increases, zero buyback authorizations and zero M&A deals — an unusually quiet disclosure window that itself argues for caution on near-term catalysts [MACRO RISK — absence of positive surprises]
Opportunities (9)
- Apple↓ (OPPORTUNITY)◆
The $7.5B raise pre-funds the 2028–2036 maturity ladder and retires the 2026 notes, strengthening an already fortress balance sheet; any pullback tied to rate fears is a buying opportunity for long-duration holders
- ◆
Clean redemption of the 2026 notes with no distress language removes an overhang; investors focused on deleveraging should note the company is retiring debt on schedule [OPPORTUNITY — balance-sheet cleanup]
- UnitedHealth↓ (OPPORTUNITY)◆
Bell's four-decade provider background (CHOP COO 2007–2015, CEO 2015–2026) gives the board direct hospital-operations expertise at a time when payer-provider dynamics are central to the story; a governance positive for long-term holders
-
Board refresh to 11 with 10 of 11 independent, average tenure 6.8 years and four women improves governance metrics; the December 8 annual meeting is a near-term catalyst for proxy-related news flow [OPPORTUNITY — governance]
- ◆
Reinstating a 19-year finance veteran as principal accounting officer with a $600K sign-on RSU grant signals the company is investing in reporting infrastructure; watch for cleaner disclosures and cost-transformation updates [OPPORTUNITY — turnaround execution]
-
Insider sales at $169.00 establish a reference price; if the stock pulls back materially below that level without a fundamental change, the CFO's decision to sell rather than hold becomes a relative-value entry signal for contrarians [OPPORTUNITY — mean reversion]
-
Quan retained 223,330 shares after selling only 20,585 — an 8.4% trim of her position, not an exit; the retained stake signals continued alignment and limits the bearish read-through [OPPORTUNITY — insider alignment]
- ◆
Four directors received routine equity awards with no sales; absence of insider selling in a biotech name with binary pipeline risk is a modest positive [OPPORTUNITY — insider stability]
- Travelers↓ (OPPORTUNITY)◆
Director grant at $402.89 with no offsetting sales keeps board alignment intact; insurers with clean insider tapes often outperform during underwriting-cycle turns
Sector Themes (5)
- Consumer Staples Insider Monetization◆
3 of 3 consumer-staples insiders in this window (P&G CFO, P&G Grooming CEO, Coca-Cola EVP) sold stock, with P&G's two sales at an identical $169.00 price and Coca-Cola's at $95.62 — a coordinated pattern of exercising and selling into strength that argues for caution on near-term staples upside
- Blue-Chip Liability Management◆
Apple raised $7.5B across seven tranches (2028–2036, coupons 4.650%–5.350%) while retiring 2026 notes, and 3M redeemed its 1.500% 2026 notes — two Dow 30 names actively terming out low-coupon debt into a higher-rate environment, a theme that will pressure interest expense across the index
- Board Refresh and Contraction◆
Microsoft shrinks to 11 directors (10 of 11 independent, 6.8-year average tenure, four women) as Walmsley withdraws, UnitedHealth adds a provider-operations CEO, and Nike rehires a finance veteran as principal accounting officer — governance turnover is elevated across the Dow 30 this week
- Absence of Operating Catalysts◆
Across 15 filings there were zero guidance updates, zero dividend or buyback actions, zero M&A transactions and zero period-over-period financial comparisons — the disclosure window is purely administrative, leaving macro and rate drivers in control of the tape
- Routine Director Compensation◆
Amgen (4 directors, ~729 shares total) and Travelers (280 shares at $402.89) issued standard equity grants with no open-market activity — board compensation remains the dominant Form 4 category, diluting the signal value of insider data this week
Watch List (8)
-
Monitor for additional Form 4s from named officers following the CFO's $5.18M and Grooming CEO's $908K sales at $169.00; a third senior sale would confirm a broader insider distribution pattern
-
Watch for follow-on Form 4s after EVP Quan Nancy's $1.97M sale at $95.62; her retained 223,330 shares make further trims the key signal
-
December 8, 2026 annual meeting — board shrinks to 11 after Walmsley's withdrawal; watch proxy advisor recommendations and any further nominee changes
- 👁
First floating-rate coupon payment February 9, 2027 and first fixed-rate payment May 9, 2027 on the new $7.5B debt; monitor rate moves for floating-tranche repricing impact
- 👁
NYSE delisting of the 1.500% 2026 notes becomes effective at the opening of business on November 20, 2026; confirm no remaining low-coupon debt requires refinancing
- 👁
McKenzie's November 9, 2026 start as principal accounting officer — watch the next 10-Q for disclosure quality and any control-environment commentary
-
Bell's board appointment effective November 9, 2026 — monitor committee assignments and any provider-strategy commentary at the next earnings call
- 👁
Four director grants in one window with zero sales — watch for any open-market purchases that would signal board confidence in the pipeline
Filing Analyses
(15)
09-11-2026
NIKE appointed Dan McKenzie, 55, as Vice President, Chief Accounting Officer, Finance Operations & Transformation, and principal accounting officer effective November 9, 2026, following his retirement from the company in July 2026 after more than 19 years in finance leadership roles. Concurrently, CFO David Denton ceased serving as Interim Corporate Controller and principal accounting officer as of the same date, though he remains EVP and CFO. McKenzie's package includes a $500,000 base salary, a 50% target bonus, a $525,000 annual LTI target, and one-time equity awards including a $600,000 sign-on RSU grant.
- · McKenzie previously served as VP, CFO, Global Operations and Technology (August 2025–July 2026), VP, CFO, North America (July 2023–July 2025), and VP, CFO, EMEA (November 2019–June 2023)
- · No arrangements or understandings, family relationships, or Item 404(a) related-party transactions exist between McKenzie and the company
- · Under the noncompete agreement, if terminated without cause the company pays monthly one-twelfth of annual base salary for 12 months; if he voluntarily resigns, monthly one-twenty fourth of annual base salary
- · The company may unilaterally waive the noncompete covenant and cease corresponding payments
- · Offer letter dated November 4, 2026; appointment announced November 9, 2026
- · McKenzie holds a Bachelor of Science in Accounting from the University of Oregon
09-11-2026
The New York Stock Exchange filed a Form 25-NSE notice with the SEC to remove 3M Co's 1.500% Notes due 2026 from listing and registration, effective at the opening of business on November 20, 2026. The notice states the entire class of these notes was redeemed or paid at maturity on November 9, 2026, and trading was suspended that day. This is a routine administrative delisting of retired debt and does not indicate any financial distress or regulatory action against 3M.
- · The filing cites Rule 12d2-2(a)(2), which covers securities redeemed or paid at maturity or retirement.
- · Suspension from trading occurred on November 9, 2026, the same day the notes were redeemed or paid at maturity.
- · Formal removal from the NYSE becomes effective at the opening of business on November 20, 2026.
09-11-2026
Executive Vice President QUAN NANCY sold 20,585 Common Stock, $.25 Par Value at $95.62 (~$1.97M). QUAN NANCY holds 223,330 shares after the transaction.
- · Executive Vice President QUAN NANCY exercised/converted 20,585 Common Stock, $.25 Par Value at $50.44 (~$1.04M)
- · Executive Vice President QUAN NANCY sold 20,585 Common Stock, $.25 Par Value at $95.62 (~$1.97M)
- · Executive Vice President QUAN NANCY exercised/converted 20,585 Employee Stock Option (Right to Buy)
09-11-2026
Director Goldwasser Lesley was awarded 280 Common Stock at $402.89 (~$113K). Goldwasser Lesley holds 280 shares after the transaction.
- · Director Goldwasser Lesley was awarded 280 Common Stock at $402.89 (~$113K)
09-11-2026
Apple Inc. consummated a $7,500,000,000 aggregate principal debt offering across seven tranches on November 9, 2026, comprising $1,250,000,000 in floating rate notes due 2028-2029 and $6,250,000,000 in fixed rate notes due 2028-2036 with coupons ranging from 4.650% to 5.350%. The largest single tranche is $2,000,000,000 of 5.350% notes due 2036, while the shortest-dated floating rate notes carry no stated fixed coupon. The notes are senior unsecured obligations ranking equally with existing unsecured debt, issued under a November 2024 indenture with The Bank of New York Mellon Trust Company as trustee, via underwriters led by Goldman Sachs, BofA Securities, Deutsche Bank Securities and J.P. Morgan Securities.
- · Interest on floating rate notes paid quarterly beginning February 9, 2027; fixed rate notes pay semi-annually beginning May 9, 2027
- · Maturity dates: 2028 Floating and 2028 Fixed on November 9, 2028; 2029 Floating and 2029 Fixed on November 9, 2029; 2031 on November 9, 2031; 2033 on November 9, 2033; 2036 on November 9, 2036
- · Underwriting Agreement dated November 5, 2026; Officer's Certificate dated November 9, 2026
- · Indenture dated November 1, 2024 between Apple and The Bank of New York Mellon Trust Company, N.A. as trustee
- · Notes are senior unsecured obligations ranking equally with Apple's other unsecured and unsubordinated debt
- · Exhibits include Underwriting Agreement (1.1), Officer's Certificate (4.1), forms of global notes (4.2-4.8), Latham & Watkins opinion (5.1) and consent (23.1)
- · Filing signed by Kevan Parekh, Senior Vice President, Chief Financial Officer, dated November 9, 2026
- · Fiscal year end 0926; SEC file number 001-36743; EIN 94-2404110
09-11-2026
Microsoft filed a DEFA14A supplement disclosing that director Emma N. Walmsley withdrew her nomination for re-election at the December 8, 2026 Annual Meeting, citing no disagreement with the company; the board will shrink to 11 members effective at the meeting. The remaining 11 nominees are 10 of 11 independent, average 6.8 years tenure and age 59, with four women; no board vacancy results and other proxy matters are unaffected.
- · Annual Meeting scheduled for December 8, 2026
- · Proxies or voting instructions for or against Ms. Walmsley's election will not be counted
- · No board vacancy will result from Ms. Walmsley's departure
- · Supplement made available online on or about November 9, 2026, at www.proxyvote.com
- · Ms. Walmsley's decision was not due to any disagreement on operations, policies, or practices
09-11-2026
UnitedHealth Group appointed Madeline S. Bell, former president and CEO of Children's Hospital of Philadelphia (CHOP), to its Board of Directors effective November 9, 2026. Bell spent four decades at CHOP, serving as COO from 2007 to 2015 and CEO from 2015 until her retirement last month. The filing contains no financial figures or period-over-period metrics; it is a governance/board composition update.
- · Bell started at CHOP as a pediatric staff nurse in 1983
- · Bell retired as CHOP CEO last month (October 2026)
- · Bell holds an M.S. in organizational dynamics from the University of Pennsylvania and a B.S. in nursing from Villanova University
- · Bell currently serves as a board director for Comcast
- · Bell previously chaired the Federal Reserve Bank of Philadelphia's Board of Directors
- · Bell is a fellow of The College of Physicians of Philadelphia and Honorary Consul of Spain
- · Filing is an 8-K under Item 5.02 (Director/Officer Departure/Election) with exhibit EX-99.1
09-11-2026
Nasdaq Stock Market LLC filed a Form 25-NSE delisting notice for Apple Inc. securities, specifically the Senior Notes Due 2026, under 17 CFR 240.12d2-2(a)(2), effective November 09, 2026. The filing reflects the maturity/redemption of a single debt security series and does not affect Apple's common stock listing. No financial performance figures were disclosed.
- · Filing is a Form 25-NSE delisting notification filed by Nasdaq, not by Apple
- · Delisting applies to Apple's Senior Notes Due 2026 under Rule 12d2-2(a)(2)
- · Effectiveness date of the delisting is November 09, 2026
- · Apple's SEC file number is 000-10030; CIK 0000320193
- · Apple's fiscal year end is September 26 (0926)
- · Apple was formerly named Apple Computer Inc. (name change 1997) and Apple Inc. (2007)
- · No monetary amounts or financial metrics were included in the filing
09-11-2026
Chief Executive Officer Nadella Satya gifted 4,704 Common Stock. Nadella Satya holds 482,058.534 shares after the transaction.
- · Chief Executive Officer Nadella Satya gifted 4,704 Common Stock
09-11-2026
Director ISHRAK OMAR was awarded 152.0351 Common Stock. ISHRAK OMAR holds 7,681.9397 shares after the transaction.
- · Director ISHRAK OMAR was awarded 152.0351 Common Stock
09-11-2026
Director Gibbs David W was awarded 278 Common Stock. Gibbs David W holds 278 shares after the transaction.
- · Director Gibbs David W was awarded 278 Common Stock
09-11-2026
Director Drake Michael V was awarded 114.0263 Common Stock. Drake Michael V holds 6,030.1896 shares after the transaction.
- · Director Drake Michael V was awarded 114.0263 Common Stock
09-11-2026
Director HOLLEY CHARLES M was awarded 184.614 Common Stock. HOLLEY CHARLES M holds 13,262.066 shares after the transaction.
- · Director HOLLEY CHARLES M was awarded 184.614 Common Stock
09-11-2026
CEO - Grooming Santos de Azevedo Juliana Monteiro sold 5,370 Common Stock at $169.00 (~$908K). Santos de Azevedo Juliana Monteiro holds 21,361.2363 shares after the transaction.
- · CEO - Grooming Santos de Azevedo Juliana Monteiro sold 5,370 Common Stock at $169.00 (~$908K)
09-11-2026
Chief Financial Officer Schulten Andre sold 30,677 Common Stock at $169.00 (~$5.18M). Schulten Andre holds 65,618.0097 shares after the transaction.
- · Chief Financial Officer Schulten Andre exercised/converted 30,677 Common Stock at $78.52 (~$2.41M)
- · Chief Financial Officer Schulten Andre sold 30,677 Common Stock at $169.00 (~$5.18M)
- · Chief Financial Officer Schulten Andre exercised/converted 30,677 Stock Option (Right to Buy)
Get daily alerts with 11 investment signals, 9 risk alerts, 9 opportunities and full AI analysis of all 15 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Dow Jones 30 Stocks SEC Filings
🇺🇸 More from United States
View all →November 10, 2026
US Pre-Market SEC Filings Roundup — November 10, 2026
US Pre-Market SEC Filings Roundup
November 10, 2026
US Merger & Acquisition SEC Filings — November 10, 2026
US Merger & Acquisition SEC Filings
November 10, 2026
USA Insider Trading Pulse — November 10, 2026
USA Insider Trading Pulse
November 10, 2026
US Corporate Board Director Changes SEC Filings — November 10, 2026
US Corporate Board Director Changes SEC Filings